Form 4: DXC’s David Herzog Receives 25.7k RSU Grant
Rhea-AI Filing Summary
DXC Technology (DXC) – Form 4 insider filing: Director David L. Herzog reported the grant of 25,700 restricted stock units (RSUs) on 08 Aug 2025. Each RSU converts to one DXC common share at no cost to the director.
• Vesting: earliest of one year after grant (08 Aug 2026) or the 2026 annual shareholder meeting. Shares settle at vesting or on a deferred date selected by the director.
• Ownership after grant: 116,401 DXC shares, including unvested RSUs. All holdings are listed as direct ownership.
The filing reflects routine director compensation rather than an open-market purchase or sale; therefore it does not alter the public float or signal a viewpoint on valuation. However, the additional equity modestly aligns the director’s incentives with shareholders.
Positive
- Director’s stake increases by 25,700 potential shares, modestly improving management–shareholder alignment.
Negative
- None.
Insights
TL;DR: Routine RSU grant; neutral signal, mild alignment benefit.
Herzog received 25.7k RSUs, boosting his stake to 116.4k shares. Because no shares were purchased with personal funds and vesting extends one year, market impact is minimal. The grant size is typical for DXC’s board compensation plan and does not indicate insider conviction, but it does incrementally tie director wealth to long-term share performance. Overall, neutral from a valuation perspective.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 25,700 | $0.00 | -- |
Footnotes (1)
- Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2026 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. Amount reported includes unvested RSUs.